Bladder cancer local staging about muscle invasion: 3.0T MRI performance following transurethral resection

  • Shi-ming ZHAO ,
  • Tie-jun YANG ,
  • Chun-miao XU ,
  • Xiao-feng GUO ,
  • Yong-kang MA ,
  • Xue-jun CHEN ,
  • Xiang LI ,
  • Chao-hong HE
Expand
  • 1. Department of Urology, Affiliated Tumor Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450008, China
    2. Department of Radiology, Affiliated Tumor Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450008, China
    3. Medical Department, Affiliated Tumor Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450008, China

Received date: 2020-04-06

  Online published: 2020-08-06

Supported by

Henan Provincial Medical Science and Technology Research Project Jointly Established by the Ministry of Education(201601025);Science and Technology Key Project of Henan Provincial Science and Technology Department(182102310180)

Abstract

Objective: To evaluate the performance of 3.0T magnetic resonance imaging examination (MRI) for the local detecting of muscle invasive bladder cancer following transurethral resection of bladder tumor (TURBT). Methods: Retrospective study identified 55 patients with pathology-proven bladder cancer who underwent transurethral resection of bladder tumor followed by 3.0T magnetic resonance imaging between September 2012 and April 2019 in our hospital. Two radiologists reviewed pelvic magnetic resonance imaging together and judged muscle invasive bladder cancer. Sensitivity, specificity and accuracy were calculated for the presence of muscle invasion by T2 weighted imaging (T2WI) only, diffusion-weighted imaging (DWI) only and T2WI+DWI compared with the findings at radical cystectomy as the reference standard. Results: Of the 55 patients with pathological results from radical cystectomy, 3.64% (2/55) had no residual disease; 29.09% (16/55) were non-muscle invasive bladder cancer on pathology, including 13 cases in T1 and 3 cases in Ta; 34.55% (19/55) were in stage T2 depending on pathology, 25.45% (14/55) in T3, and 7.27% (4/55) in T4. The average age was 60.76 years, ranging from 42 to 82 years. There were 48 males and 7 females in our study. Before pelvic MRI examination, all the patients received transurethral resection of bladder tumor, including 16 cases taking the operation in our hospital and 39 cases in other hospitals. The interval between the pelvic MRI examination and transurethral resection of bladder tumor was more than 2 weeks in all the patients. They all underwent radical cystectomy within 1 month after the pelvic MRI examination, and no patient underwent radiotherapy or chemotherapy in our study during the interval between the MRI examination and radical cystectomy. T2WI only, DWI only, and T2WI+DWI of 3.0T magnetic resonance imaging for readers were with sensitivity: 94.59%, 83.78%, 91.89%; with specificity: 66.67%, 77.78%, 72.22% and with accuracy: 85.45%, 81.82%, 85.45%, respectively. Conclusion: 3.0T MRI may have a role in diagnosing muscle invasive bladder cancer following TURBT. T2WI has the advantage of detecting the location of bladder tumor, and DWI has the advantage of differentiating between the benign and malignant lesion. 3.0T MRI T2WI+DWI has a good utility in the detection of muscle invasive bladder cancer following TURBT with satisfied accuracy.

Cite this article

Shi-ming ZHAO , Tie-jun YANG , Chun-miao XU , Xiao-feng GUO , Yong-kang MA , Xue-jun CHEN , Xiang LI , Chao-hong HE . Bladder cancer local staging about muscle invasion: 3.0T MRI performance following transurethral resection[J]. Journal of Peking University(Health Sciences), 2020 , 52(4) : 701 -704 . DOI: 10.19723/j.issn.1671-167X.2020.04.020

References

[1] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China 2015[J]. CA Cancer J Clin, 2016,66(2):115-132.
[2] 中华医学会泌尿外科学分会, 中国膀胱癌联盟. 非肌层浸润性膀胱癌二次电切中国专家共识[J]. 中华泌尿外科杂志, 2017,38(8):561-563.
[3] Van der Pol CB, Shinagare AB, Tirumani SH, et al. Bladder cancer local staging: multiparametric MRI performance following transurethral resection[J]. Abdom Radiol (NY), 2018,43(9):2412-2423.
[4] Lee CH, Tan CH, Faria SC, et al. Role of imaging in the local staging of urothelial carcinoma of the bladder[J]. AJR Am J Roentgenol, 2017,208(6):1193-1205.
[5] 孔德波, 谢立平. 泌尿男生殖系肿瘤第七版TNM分期的变化及解读[J]. 中华泌尿外科杂志, 2012,33(2):149-151.
[6] 夏威利, 王立峰, 张孝先, 等. 3.0T磁共振功能成像在术前诊断肌层浸润性膀胱癌的价值[J]. 临床放射学杂志, 2018,37(11):1860-1864.
[7] Takeuchi M, Sasaki S, Ito M, et al. Urinary bladder cancer: diffusion-weighted MR imaging accuracy for diagnosing T stage and estimating histologic grade[J]. Radiology, 2009,251(1):112-121.
[8] McInnes MD, Siemens DR, Mackillop WJ, et al. Utilisation of preoperative imaging for muscle-invasive bladder can-cer: a population-based study[J]. BJU Int, 2016,117(3):430-438.
[9] Tekes A, Kame L, Imam K, et al. Dynamic MRI of bladder can-cer: evaluation of staging accuracy[J]. AJR Am J Roentgenol, 2005,184(1):121-127.
[10] Yoshida S, Takahara T, Kwee TC, et al. DWI as an imaging biomarker for bladder cancer[J]. AJR Am J Roentgenol, 2017,208(6):1218-1228.
[11] Panebianco V, Narumi Y, Altun E, et al. Multiparametric magnetic resonance imaging for bladder cancer: development of VI-RADS (vesical imaging-reporting and data system)[J]. Eur Urol, 2018,74(3):294-306.
[12] 王良, Li QB, Hebert AV. 膀胱影像报告和数据系统解读[J]. 中华放射学杂志, 2019,53(3):164-169.
Outlines

/